Last reviewed · How we verify

Oxytocin 2 mIU/mL

Assistance Publique - Hôpitaux de Paris · FDA-approved active Small molecule

Oxytocin 2 mIU/mL is a Oxytocin receptor agonist Small molecule drug developed by Assistance Publique - Hôpitaux de Paris. It is currently FDA-approved for Induction or augmentation of labor, Control of postpartum hemorrhage, Promotion of milk letdown in lactation.

Oxytocin binds to oxytocin receptors on uterine smooth muscle and mammary gland tissue to stimulate contractions and milk ejection.

Oxytocin binds to oxytocin receptors on uterine smooth muscle and mammary gland tissue to stimulate contractions and milk ejection. Used for Induction or augmentation of labor, Control of postpartum hemorrhage, Promotion of milk letdown in lactation.

At a glance

Generic nameOxytocin 2 mIU/mL
SponsorAssistance Publique - Hôpitaux de Paris
Drug classOxytocin receptor agonist
TargetOxytocin receptor (OXTR)
ModalitySmall molecule
Therapeutic areaObstetrics and Gynecology
PhaseFDA-approved

Mechanism of action

Oxytocin is a neurohypophyseal hormone that acts as an agonist at oxytocin receptors, G-protein coupled receptors present on myometrial cells and lactating breast tissue. Receptor activation triggers increased intracellular calcium, leading to smooth muscle contraction of the uterus during labor and milk letdown during lactation. It is also involved in social bonding and maternal behavior.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Oxytocin 2 mIU/mL

What is Oxytocin 2 mIU/mL?

Oxytocin 2 mIU/mL is a Oxytocin receptor agonist drug developed by Assistance Publique - Hôpitaux de Paris, indicated for Induction or augmentation of labor, Control of postpartum hemorrhage, Promotion of milk letdown in lactation.

How does Oxytocin 2 mIU/mL work?

Oxytocin binds to oxytocin receptors on uterine smooth muscle and mammary gland tissue to stimulate contractions and milk ejection.

What is Oxytocin 2 mIU/mL used for?

Oxytocin 2 mIU/mL is indicated for Induction or augmentation of labor, Control of postpartum hemorrhage, Promotion of milk letdown in lactation.

Who makes Oxytocin 2 mIU/mL?

Oxytocin 2 mIU/mL is developed and marketed by Assistance Publique - Hôpitaux de Paris (see full Assistance Publique - Hôpitaux de Paris pipeline at /company/assistance-publique-h-pitaux-de-paris).

What drug class is Oxytocin 2 mIU/mL in?

Oxytocin 2 mIU/mL belongs to the Oxytocin receptor agonist class. See all Oxytocin receptor agonist drugs at /class/oxytocin-receptor-agonist.

What development phase is Oxytocin 2 mIU/mL in?

Oxytocin 2 mIU/mL is FDA-approved (marketed).

What are the side effects of Oxytocin 2 mIU/mL?

Common side effects of Oxytocin 2 mIU/mL include Uterine hyperstimulation, Nausea and vomiting, Headache, Hypertension, Water intoxication (with prolonged high-dose infusion).

What does Oxytocin 2 mIU/mL target?

Oxytocin 2 mIU/mL targets Oxytocin receptor (OXTR) and is a Oxytocin receptor agonist.

Related